Saturday 17 October 2026 Export ASND’s income statement to Excel — free account

Ascendis Pharma A/S

Ascendis Pharma A/S’s revenue for fiscal 2025 (year ended December 2025) was $814.8 million, up 107.1% from fiscal 2024. In the quarter to June 2026, revenue grew 119.9%, EPS grew 612.3%, free cash flow grew 2,335.9% and total debt fell 41.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

225.78 0.84 −0.37%

Follow ASND

Alert me

Market cap: $14.9B
P/E: 16.3×
Fwd P/E: 13.0×
Dividend yield: —
F-score: 5/9
Altman Z: 2.02
Beneish M: −2.51
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	19.23	24.33	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	14.16	14.15	15.86	16.72
P/FCF ratio Full definition →	44.29	287.13	251.54	0.00
P/Operating CF Full definition →	52.39	(1,561.25)	154.27	6,759.70
P/B ratio Full definition →	10.28	24.70	0.00	0.00
Price to Tangible BV Full definition →	10.30	24.89	0.00	0.00
EV/Sales Full definition →	13.81	14.53	16.22	17.16
EV/EBITDA Full definition →	52.11	3,004.22	0.00	0.00
EV/Operating CF Full definition →	41.43	216.16	216.68	(109.45)
EV/FCF Full definition →	43.20	294.85	257.17	(103.62)
Quick Ratio Full definition →	2.23	0.68	0.72	0.70
Current Ratio Full definition →	2.99	1.00	1.04	1.03
Net Debt/EBITDA Full definition →	(1.61)	11.15	36.90	17.98
Debt/Assets Full definition →	19.69%	44.76%	66.93%	70.46%
Debt/Equity Full definition →	0.31	1.84	(5.35)	(4.67)
Asset Turnover Full definition →	0.62	0.58	0.59	0.57
Operating CF/Net income Full definition →	1.36	(0.01)	(1.95)	(0.03)
Capex/Depreciation Full definition →	(0.70)	(1.83)	(0.73)	(0.05)
Interest Coverage Full definition →	15.56	0.37	0.04	0.16
Research and Development Expense of Revenue Full definition →	22.37%	23.94%	33.08%	31.31%
Selling, General and Administrative Expense of Revenue Full definition →	51.09%	58.89%	56.19%	53.08%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	8.67%	12.31%	10.98%	15.09%
Graham Net Nets Full definition →	0.04	(0.03)	(0.03)	(0.03)
Graham Number Full definition →	90.00	44.25	16.95	17.87
Earnings Yield Full definition →	5.20%	4.11%	(1.97%)	(2.13%)
Free Cash Flow Yield Full definition →	2.26%	0.35%	0.40%	(0.99%)
Revenue per Share Full definition →	6.13	4.68	4.61	4.11
Operating CF per Share Full definition →	5.09	(0.15)	1.38	0.03
Capex per Share Full definition →	(0.06)	(0.15)	(0.06)	0.00
Free Cash Flow per Share Full definition →	5.03	(0.29)	1.32	0.03
Cash per Share Full definition →	14.68	10.87	11.50	10.37
Shareholders Equity per Share Full definition →	25.96	9.26	(3.04)	(3.35)
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	25.96	9.26	(3.04)	(3.35)
Free Cash Flow Full definition →	323.87	(18.06)	80.13	1.56
Working Capital Full definition →	1,076.11	(5.18)	44.80	36.58
Capital Expenditures Full definition →	(3.70)	(9.03)	(3.65)	(0.23)
Net Current Asset Value Full definition →	628.88	(459.93)	(403.24)	(363.58)
EV/EBIT Full definition →	55.60	0.00	0.00	0.00
Capex to Sales Full definition →	0.01	0.03	0.01	0.00
Price to Operating Income Full definition →	57.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	199.09	155.52	185.21	113.74
Average Payables Full definition →	113.61	90.43	103.44	87.32
Average Inventory Full definition →	352.75	338.33	330.52	322.45
Average Assets Full definition →	1,946.47	1,731.43	1,375.03	1,276.26
Average Common Equity Full definition →	728.64	185.58	(149.30)	(155.24)

Show all line items

Columns are period end dates

Stockrow Weekly